Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Ming Hong

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Gut Pathogens|June 17, 2023
Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver diseaseMeng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, et al.
Gut Pathogens|May 22, 2023
Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver diseaseMeng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingTung-Hung Su, Sih-Han Liao, Chun-Ming Hong, et al.
The American Journal of Gastroenterology|February 22, 2022
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate PhaseTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology|May 27, 2017
A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patientsChen-Hua Liu, Chun-Jen Liu, Chun-Ming Hong, et al.
Alimentary Pharmacology & Therapeutics|January 19, 2021
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 5, 2023
Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resectionTung-Hung Su, Shang-Chin Huang, Chi-Ling Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 23, 2023
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and SeroconversionShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.
Liver Cancer|March 13, 2024
Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan CriteriaChian-Tzu Huang, Yu-Long Chu, Tung-Hung Su, et al.
Hepatology International|May 29, 2023
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis BShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Gut Pathogens|June 17, 2023
Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver diseaseMeng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, et al.
Gut Pathogens|May 22, 2023
Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver diseaseMeng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingTung-Hung Su, Sih-Han Liao, Chun-Ming Hong, et al.
The American Journal of Gastroenterology|February 22, 2022
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate PhaseTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology|May 27, 2017
A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patientsChen-Hua Liu, Chun-Jen Liu, Chun-Ming Hong, et al.
Alimentary Pharmacology & Therapeutics|January 19, 2021
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 5, 2023
Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resectionTung-Hung Su, Shang-Chin Huang, Chi-Ling Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 23, 2023
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and SeroconversionShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.
Liver Cancer|March 13, 2024
Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan CriteriaChian-Tzu Huang, Yu-Long Chu, Tung-Hung Su, et al.
Hepatology International|May 29, 2023
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis BShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.
Pageof 4